Aptamer Group Plc (GB:APTA)
LSE:APTA
APTA Stock Chart & Stats
0.80 p
-0.01 p(-2.86%)
At close: 4:00 PM EST
0.80 p
-0.01 p(-2.86%)
Day’s Range― - ―
52-Week Range0.23 p - 1.57 p
Previous CloseN/A
Volume3.91M
Average Volume (3M)15.29M
Market Cap
£16.86M
Enterprise Value15.66M
Total Cash (Recent Filing)£1.53M
Total Debt (Recent Filing)£333.00K
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Oct 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,696,978,300
10 Day Avg. Volume14,821,052
30 Day Avg. Volume15,285,032
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)5.32
Price to Sales (P/S)6.11
P/FCF Ratio-3.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Aptamer Platform And Diversified End MarketsAptamer Group's platform targets diagnostics, therapeutics and bioprocessing, giving the company multiple durable end markets. A proprietary discovery/optimisation capability supports recurring service revenue and product opportunities, enabling diversified pathways to scale if adoption progresses.
Improved Leverage ManagementAn improved debt-to-equity ratio signals reduced leverage and better capital structure management. Lower relative debt improves financial flexibility, reduces cash interest burden and lengthens runway, which supports continued R&D or commercialization investments without immediate refinancing pressure.
Signs Of Improving Free Cash Flow GrowthA slight improvement in free cash flow growth, if sustained, can meaningfully extend operational runway and reduce reliance on external funding. Improved FCF trends provide management more optionality to prioritize commercialization or targeted R&D over near-term cash preservation measures.
Bears Say
Severe Revenue DeclineA near-total revenue collapse undermines market traction and scale economics, weakening the commercial foundation for recurring revenue and product adoption. This magnitude of decline makes it difficult to support fixed costs, fund pipelines organically, and achieve sustainable top-line recovery without new commercial wins.
Persistent Negative Operating And Free Cash FlowOngoing negative operating and free cash flows indicate continued cash burn and constrained internal funding for growth. Over a multi-month horizon this necessitates external capital, asset sales, or aggressive cost cutting, each of which can impair R&D timelines and long-term commercial execution.
Negative Return On Equity And Profitability IssuesSustained negative ROE signals structural inability to generate returns from invested capital. Persisting unprofitability increases the likelihood of dilutive financing and weakens strategic flexibility, hampering the company's capacity to form partnerships or invest in commercial scale-up over the medium term.
Aptamer Group Plc News
APTA FAQ
What was Aptamer Group Plc’s price range in the past 12 months?
Aptamer Group Plc lowest share price was 0.23 p and its highest was 1.57 p in the past 12 months.
What is Aptamer Group Plc’s market cap?
Aptamer Group Plc’s market cap is £16.86M.
When is Aptamer Group Plc’s upcoming earnings report date?
Aptamer Group Plc’s upcoming earnings report date is Oct 20, 2026 which is in 206 days.
How were Aptamer Group Plc’s earnings last quarter?
Aptamer Group Plc released its earnings results on Mar 25, 2026. The company reported 0 p earnings per share for the quarter, the consensus estimate of N/A by 0 p.
Is Aptamer Group Plc overvalued?
According to Wall Street analysts Aptamer Group Plc’s price is currently Overvalued.
Does Aptamer Group Plc pay dividends?
Aptamer Group Plc does not currently pay dividends.
What is Aptamer Group Plc’s EPS estimate?
Aptamer Group Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptamer Group Plc have?
Aptamer Group Plc has 2,696,978,300 shares outstanding.
What happened to Aptamer Group Plc’s price movement after its last earnings report?
Aptamer Group Plc reported an EPS of 0 p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Aptamer Group Plc?
Currently, no hedge funds are holding shares in GB:APTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aptamer Group Plc
Aptamer Group Plc (APTA) is a biotechnology company that specializes in the development of novel aptamer-based technologies for various applications in diagnostics, therapeutics, and research. The company operates primarily in the life sciences sector, focusing on providing high-quality, synthetic aptamers—short, single-stranded oligonucleotides that can bind to specific target molecules. Aptamer Group's core products and services include the design and production of aptamers for use in pharmaceutical development, as well as tools for biomarker discovery and diagnostics.
Technical Analysis
Avacta Group plc
―
Bioventix
―
Oxford BioDynamics
―
Fusion Antibodies Plc
―
Arecor Therapeutics PLC
―
Options Prices
Currently, No data available
---